OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Steven Paul

2 Projects | 1 Researchers | $750,000 Invested

2013

Weill Medical College of Cornell University

Steven Paul, MD

Gene Delivery of Apolipoprotein E2 as a Treatment for Alzheimer's Disease

  • Funding Amount: $500,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2011

Weill Medical College of Cornell University

Steven Paul, MD

Gene delivery of apolipoprotein E2 as a treatment for Alzheimer's disease.

  • Funding Amount: $250,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed